Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 000552.SZ
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 23.00 1.99 1.62
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 52.45 -2.22 -4.68
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 5.08 3.14 2.98
Cash -0.83 1.52 1.53
Capex 59.05 -0.09 -0.21
Free Cash Flow 35.59 -0.14 -0.22
Revenue 6.60 0.53 0.49
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 1.52 0.37 0.36
Operating Margin 149.00 0.22 0.09
ROA 195.77 0.02 < 0.005
ROE 186.92 0.03 0.01
ROIC 186.20 0.02 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 000552.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 000552.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 000552.SZ is permitted for members.